HHealth Read More Prime and pull vaccine approach prevents genital herpes infectionJune 22, 2026 Genital herpes is a lifelong infection. While available treatments can manage symptoms, they cannot cure the infection or…
HHealth Read More Antisense oligonucleotides reverse rare neurodevelopmental disorder in preclinical modelsApril 23, 2026 Scientists at St. Jude Children’s Research Hospital have found they can reverse the effects of HNRNPH2-related neurodevelopmental disorder using…
MMedication Read More PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT DataApril 1, 2026 – PGN-EDODM1 was generally well-tolerated with all adverse events mild or moderate and no serious adverse events reported…
TTechnology Read More Picoquant invests in Fluobrick Solutions to simplify access to single molecule researchSeptember 25, 2025 PicoQuant GmbH announces its investment in FluoBrick Solutions GmbH, a newly founded Berlin-based start-up focused on giving life…